LinglingDuMD

Oncology • Jefferson, LA

Physician

Join to view full profile

Dr. Du is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Du's full profile

Already have an account?

Office
1514 Jefferson Hwy
Jefferson, LA 70121
Phone+1 866-624-7637

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2017
Cleveland Clinic FoundationResidency, Internal Medicine, 2011 - 2014
Beijing Medical UniversityClass of 2011

Certifications & Licensure

LA State Medical License 2017 - 2025
MS State Medical License 2019 - 2025
MO State Medical License 2014 - 2018
OH State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.
Nilofer Azad, Zishuo Hu, Ilyas Sahin, Renuka Iyer, Olivia Aranha
Future Oncology. 2024-01-01
5 citations
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma.
Patrick M. Grierson, Andrea S. Teague, Rama Suresh, Kian-Huat Lim, Manik Amin
Journal of Gastrointestinal Oncology. 2020-02-01
3 citations
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer.
Nooshin Hashemi Sadraei, Yan Feng, Lingling Du, Pingfu Fu, Sulsal Haque
Lung Cancer. 2018-12-01

Journal Articles

Expression of LC3B and FIP200/Atg17 in Brain Metastases of Breast Cancer
Manmeet S Ahluwalia, Lingling Du, Adam Lauko, Robert J Weil, Samuel T Chao, Journal of Neuro-Oncology